News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Daiichi Pharmaceutical Korea To Become Wholly Owned Subsidiary Of Daiichi Pharmaceutical Co., Ltd.


10/10/2006 9:45:17 AM

Tokyo (JCN) - Daiichi Sankyo Co., Ltd. has announced that its subsidiary Daiichi Pharmaceutical Co., Ltd. has signed an agreement to acquire 100% of the shares of Seoul-based Daiichi Pharmaceutical Korea Co., Ltd. ('KDP'), a joint venture with Jeil Pharmaceutical Co., Ltd. The acquisition will take effect on October 13, when KDP becomes a wholly owned subsidiary of Daiichi Pharmaceutical. With this acquisition, the Daiichi Sankyo Group plans to actively expand its business operations throughout Asia.

Copyright(C) 2006 Japan Corporate News Network. www.japancorp.net All rights reserved.

>>> Discuss This Story


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES